By Canadian Press

US recommends ‘pause’ for J&J vaccine over clot reports

Apr 13, 2021 | 4:31 AM

WASHINGTON — The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said it was investigating clots in six women in the days after vaccination, in combination with reduced platelet counts. More than 6.8 million doses of the J&J vaccine have been administered in the U.S.

U.S. federal distribution channels, including mass vaccination sites, will pause the use of the J&J shot, and states and other providers are expected to follow.

CDC’s Advisory Committee on Immunization Practices will meet Wednesday to discuss the cases and the FDA has also launched an investigation of the cases.

“Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr. Anne Schuchat, Principal Deputy Director of the CDC and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said in a joint statement.

firm handshake

B.C. NDP government, Greens reach 'shared priorities' agreement

1h ago

young volunteers

'Make a big difference:' Nanaimo volunteers collecting warm clothing for those in need

3h ago

strong storm

Wind warning issued as Pacific storm approaches Island

4h ago

Zeke Miller, The Associated Press